The identification of Nor1 as a transcriptional regulator of genes involved in microtubule reorganization provides new insights into the hierarchical role of SUMOylation in fine-tuning neuronal gene expression networks and warrants further investigation of Nor1 as a potential therapeutic target in neurodegenerative diseases associated with microtubule dysfunction. This evidence concerns the gene NR4A3 and neurodegenerative disease.